Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jan;45(1):24-36.
doi: 10.1161/STROKEAHA.113.002707. Epub 2013 Nov 21.

Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants

Martin Dichgans  1 , Rainer Malik, Inke R König, Jonathan Rosand, Robert Clarke, Solveig Gretarsdottir, Gudmar Thorleifsson, Braxton D Mitchell, Themistocles L Assimes, Christopher Levi, Christopher J O'Donnell, Myriam Fornage, Unnur Thorsteinsdottir, Bruce M Psaty, Christian Hengstenberg, Sudha Seshadri, Jeanette Erdmann, Joshua C Bis, Annette Peters, Giorgio B Boncoraglio, Winfried März, James F Meschia, Sekar Kathiresan, M Arfan Ikram, Ruth McPherson, Kari Stefansson, Cathie Sudlow, Muredach P Reilly, John R Thompson, Pankaj Sharma, Jemma C Hopewell, John C Chambers, Hugh Watkins, Peter M Rothwell, Robert Roberts, Hugh S Markus, Nilesh J Samani, Martin Farrall, Heribert Schunkert; METASTROKE Consortium; CARDIoGRAM Consortium; C4D Consortium; International Stroke Genetics Consortium
Collaborators, Affiliations
Review

Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants

Martin Dichgans et al. Stroke. 2014 Jan.

Abstract

Background and purpose: Ischemic stroke (IS) and coronary artery disease (CAD) share several risk factors and each has a substantial heritability. We conducted a genome-wide analysis to evaluate the extent of shared genetic determination of the two diseases.

Methods: Genome-wide association data were obtained from the METASTROKE, Coronary Artery Disease Genome-wide Replication and Meta-analysis (CARDIoGRAM), and Coronary Artery Disease (C4D) Genetics consortia. We first analyzed common variants reaching a nominal threshold of significance (P<0.01) for CAD for their association with IS and vice versa. We then examined specific overlap across phenotypes for variants that reached a high threshold of significance. Finally, we conducted a joint meta-analysis on the combined phenotype of IS or CAD. Corresponding analyses were performed restricted to the 2167 individuals with the ischemic large artery stroke (LAS) subtype.

Results: Common variants associated with CAD at P<0.01 were associated with a significant excess risk for IS and for LAS and vice versa. Among the 42 known genome-wide significant loci for CAD, 3 and 5 loci were significantly associated with IS and LAS, respectively. In the joint meta-analyses, 15 loci passed genome-wide significance (P<5×10(-8)) for the combined phenotype of IS or CAD and 17 loci passed genome-wide significance for LAS or CAD. Because these loci had prior evidence for genome-wide significance for CAD, we specifically analyzed the respective signals for IS and LAS and found evidence for association at chr12q24/SH2B3 (PIS=1.62×10(-7)) and ABO (PIS=2.6×10(-4)), as well as at HDAC9 (PLAS=2.32×10(-12)), 9p21 (PLAS=3.70×10(-6)), RAI1-PEMT-RASD1 (PLAS=2.69×10(-5)), EDNRA (PLAS=7.29×10(-4)), and CYP17A1-CNNM2-NT5C2 (PLAS=4.9×10(-4)).

Conclusions: Our results demonstrate substantial overlap in the genetic risk of IS and particularly the LAS subtype with CAD.

Keywords: coronary artery disease; genetics; meta-analysis; polymorphism, single nucleotide; stroke.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

All authors affiliated with deCODE are employees of deCODE, a biotechnology company. Some deCODE employees own stock options in deCODE. The other authors declare that they have no conflicts of interest

Figures

Figure 1
Figure 1
QQ plots for individual vascular phenotypes considering variants reaching a low threshold of significance (p<0.01) in alternate vascular phenotypes: CAD variants in all IS (left) and all IS variants in CAD (right) (A), CAD variants in LAS (left) and LAS variants in CAD (right) (B); CAD variants in CES (left) and CES variants in CAD (right) (C). SNPs with effects going into the same direction in the respective samples are shown in black. SNPs with effects going into opposite directions in the respective samples are shown in light blue. Data were drawn from METASTROKE, CARDIoGRAM and C4D. Red line: expected line corresponding to a normal distribution; black lines represent 95% confidence intervals of the expected distribution. For display purposes variants from the 9p21 locus are omitted from the figure. p-values correspond to the analysis of directionally consistent SNPs (black line).
Figure 2
Figure 2
Manhattan plots of –log10(p) against genomic position: Results are shown for (A) the combined endpoint of all IS or CAD and (B) the combined endpoint of LAS or CAD. Genome-wide meta-analysis association results by genomic position at autosomal SNPs. Data were drawn from METASTROKE and CARDIoGRAM.
Figure 2
Figure 2
Manhattan plots of –log10(p) against genomic position: Results are shown for (A) the combined endpoint of all IS or CAD and (B) the combined endpoint of LAS or CAD. Genome-wide meta-analysis association results by genomic position at autosomal SNPs. Data were drawn from METASTROKE and CARDIoGRAM.
Figure 3
Figure 3
Regional association plots (left) and corresponding Spearman correlation plots (right) of p-values for individual variants of (A) the chr12q24/SH2B3 locus for IS and CAD and (B) the RAI1-PEMT-RASD1 locus for LAS and CAD. For clarity, only a subset of variants is displayed (see Supplementary Figure II for all variants). Data were drawn from METASTROKE and CARDIoGRAM.
Figure 4
Figure 4
Regional association plots (left) and corresponding Spearman correlation plots (right) of (A) the SORT1 locus for IS and CAD, (B) the TCF21 locus for LAS and CAD, and (C) the HDAC9 locus for LAS and CAD. For clarity, only a subset of variants is displayed (see Supplementary Figure II for all variants). Data were drawn from METASTROKE and CARDIoGRAM.
See this image and copyright information in PMC

Similar articles

  • Genetic Risk Factors for Ischemic and Hemorrhagic Stroke.
    Chauhan G, Debette S. Chauhan G, et al. Curr Cardiol Rep. 2016 Dec;18(12):124. doi: 10.1007/s11886-016-0804-z. Curr Cardiol Rep. 2016. PMID: 27796860 Free PMC article. Review.
  • Genetics of Coronary Artery Disease.
    McPherson R, Tybjaerg-Hansen A. McPherson R, et al. Circ Res. 2016 Feb 19;118(4):564-78. doi: 10.1161/CIRCRESAHA.115.306566. Circ Res. 2016. PMID: 26892958 Review.
  • Multiple associated variants increase the heritability explained for plasma lipids and coronary artery disease.
    Tada H, Won HH, Melander O, Yang J, Peloso GM, Kathiresan S. Tada H, et al. Circ Cardiovasc Genet. 2014 Oct;7(5):583-7. doi: 10.1161/CIRCGENETICS.113.000420. Epub 2014 Aug 28. Circ Cardiovasc Genet. 2014. PMID: 25170055 Free PMC article.
  • Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies.
    Traylor M, Farrall M, Holliday EG, Sudlow C, Hopewell JC, Cheng YC, Fornage M, Ikram MA, Malik R, Bevan S, Thorsteinsdottir U, Nalls MA, Longstreth W, Wiggins KL, Yadav S, Parati EA, Destefano AL, Worrall BB, Kittner SJ, Khan MS, Reiner AP, Helgadottir A, Achterberg S, Fernandez-Cadenas I, Abboud S, Schmidt R, Walters M, Chen WM, Ringelstein EB, O'Donnell M, Ho WK, Pera J, Lemmens R, Norrving B, Higgins P, Benn M, Sale M, Kuhlenbäumer G, Doney AS, Vicente AM, Delavaran H, Algra A, Davies G, Oliveira SA, Palmer CN, Deary I, Schmidt H, Pandolfo M, Montaner J, Carty C, de Bakker PI, Kostulas K, Ferro JM, van Zuydam NR, Valdimarsson E, Nordestgaard BG, Lindgren A, Thijs V, Slowik A, Saleheen D, Paré G, Berger K, Thorleifsson G; Australian Stroke Genetics Collaborative, Wellcome Trust Case Control Consortium 2 (WTCCC2); Hofman A, Mosley TH, Mitchell BD, Furie K, Clarke R, Levi C, Seshadri S, Gschwendtner A, Boncoraglio GB, Sharma P, Bis JC, Gretarsdottir S, Psaty BM, Rothwell PM, Rosand J, Meschia JF, Stefansson K, Dichgans M, Markus HS; International Stroke Genetics Consortium. Traylor M, et al. Lancet Neurol. 2012 Nov;11(11):951-62. doi: 10.1016/S1474-4422(12)70234-X. Epub 2012 Oct 5. Lancet Neurol. 2012. PMID: 23041239 Free PMC article.
  • 9p21 is a shared susceptibility locus strongly for coronary artery disease and weakly for ischemic stroke in Chinese Han population.
    Ding H, Xu Y, Wang X, Wang Q, Zhang L, Tu Y, Yan J, Wang W, Hui R, Wang CY, Wang DW. Ding H, et al. Circ Cardiovasc Genet. 2009 Aug;2(4):338-46. doi: 10.1161/CIRCGENETICS.108.810226. Epub 2009 May 28. Circ Cardiovasc Genet. 2009. PMID: 20031605
See all similar articles

Cited by

See all "Cited by" articles

References

    1. Bonita R. Epidemiology of stroke. Lancet. 1992;339:342–344. - PubMed
    1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the global burden of disease study 2010. Lancet. 2013;380:2095–2128. - PMC - PubMed
    1. Kannel WB, Wolf PA, Verter J. Manifestations of coronary disease predisposing to stroke. The framingham study. JAMA : the journal of the American Medical Association. 1983;250:2942–2946. - PubMed
    1. Sacco RL, Benjamin EJ, Broderick JP, Dyken M, Easton JD, Feinberg WM, et al. Prevention and rehabilitation of stroke. Risk factors. Stroke; a journal of cerebral circulation; American heart association prevention conference. Iv; 1997. pp. 1507–1517. - PubMed
    1. Iso H, Jacobs DR, Jr, Wentworth D, Neaton JD, Cohen JD. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. The New England journal of medicine. 1989;320:904–910. - PubMed

Publication types

MeSH terms

Associated data

Grants and funding

-